| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/29/2013 | CN102293953B Ovientvine, chrysanthemum and stiff silkworm decoction for treating idiopathic facial palsy |
| 05/29/2013 | CN102283876B Method for producing ternary tablets by using bee products and American ginseng as main materials |
| 05/29/2013 | CN102247469B Preparation method for acute bronchitis syrup |
| 05/29/2013 | CN102247368B Compound acrivastine sustained release tablets, and preparation method thereof |
| 05/29/2013 | CN102204887B In-situ formed acyclovir spraying agent and preparation method thereof |
| 05/29/2013 | CN102188688B Traditional Chinese medicine capable of treating cervical and lumbar vertebra hyperosteogeny |
| 05/29/2013 | CN102178659B Clarithromycin entericcoated tablet and preparation method thereof |
| 05/29/2013 | CN102133193B Faropenem sodium powder injection |
| 05/29/2013 | CN102038644B Lutein water-soluble powder and preparation process thereof |
| 05/29/2013 | CN102026664B Composition for stabilizing Beta-blocker, and transdermally absorbable preparation comprising the composition |
| 05/29/2013 | CN101925355B Fentanyl-containing patch for external use |
| 05/29/2013 | CN101917977B Formulations of nonopioid and confined opioid analgesics |
| 05/29/2013 | CN101883557B Novel thermosensitive liposomes containing therapeutic agents |
| 05/29/2013 | CN101883556B Transdermal delivery system for hormones and steroids |
| 05/29/2013 | CN101851247B Composition containing clopidogrel bisulfate crystal particles |
| 05/29/2013 | CN101812491B Method for producing pleurotus ferulae polysaccharide and oral liquid thereof through fermentation |
| 05/29/2013 | CN101791300B Acipimox push-pull osmotic pump controlled release tablet and preparation method thereof |
| 05/29/2013 | CN101785820B Medicinal preparation used for treating dysmenorrhea and preparation method thereof |
| 05/29/2013 | CN101730714B Lung volume reduction therapy using crosslinked non-natural polymers |
| 05/29/2013 | CN101730533B Stable pharmaceutical composition comprising a hydrosoluble vinflunine salt |
| 05/29/2013 | CN101686898B Process for producing preparation for oral administration |
| 05/29/2013 | CN101669924B 贴剂和贴剂制剂 Patch and patch preparation |
| 05/29/2013 | CN101583348B Formation of medically useful gels comprising microporous particles and methods of use |
| 05/29/2013 | CN101557720B Active ingredient delivery system with an amorphous metal salt as carrier |
| 05/29/2013 | CN101528199B 改良的鼻烟组合物 Improved snuff composition |
| 05/29/2013 | CN101495095B Process for the precipitation and isolation of 6,6-dimethyl-3-aza-bicyclo [3.1.0] hexane-amide compounds by controlled precipitation and pharmaceutical formulations containing same |
| 05/29/2013 | CN101491548B Suspension suitable for animal directly-drinking and preparation method thereof |
| 05/29/2013 | CN101485796B Chinese medicinal composition for treating insomnia as well as preparation method thereof |
| 05/29/2013 | CN101417081B Quality detection method of Longfengbao capsule |
| 05/29/2013 | CN101407514B Tiotropium salts, tiotropium salts pharmaceutical formulations and uses thereof |
| 05/29/2013 | CN101394850B Orodispersible domperidone tablets |
| 05/29/2013 | CN101287443B Pulse releasing system controlled by pH, preparation method and application thereof |
| 05/29/2013 | CN101235041B Four kinds of tripterygium wilfordii derivative and preparing method of pharmaceutics thereof |
| 05/29/2013 | CN101225424B Single-glucopyranoside of cyclomembranousol, preparation method, medicament combination and uses thereof |
| 05/29/2013 | CN101184474B A closed container comprising an activated factor vii polypeptide, processes for the preparation of the same, and a kit and a method for use of the kit |
| 05/29/2013 | CN101157612B Organic acid menthol derivative and transdermal drug delivery preparation having the same |
| 05/29/2013 | CN101022808B Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |
| 05/28/2013 | US8450481 Compounds for inhibiting protein aggregation, and methods for making and using them |
| 05/28/2013 | US8450380 Method for implementing active ingredients in order to protect them and optimize their delivery method |
| 05/28/2013 | US8450339 Compositions for treatment of common cold |
| 05/28/2013 | US8449920 Sustained release beads and suspensions including the same for sustained delivery of active ingredients |
| 05/28/2013 | US8449919 Composition and method for preparing alginate nanocapsules |
| 05/28/2013 | US8449918 Composition exhibiting enhanced formulation stability and delivery of topical active ingredients |
| 05/28/2013 | US8449917 Solid herbicide compositions with built-in adjuvant |
| 05/28/2013 | US8449916 Antimicrobial compositions and methods |
| 05/28/2013 | US8449915 Pharmaceutical composition of nanoparticles |
| 05/28/2013 | US8449914 releases carvedilol at least partly in R(+) or S(-) form after oral administration in such a manner that a prolonged residence of carvedilol is obtained In the circulatory system compared with the known carvedilol compositions |
| 05/28/2013 | US8449913 Methods of administering a dermatological agent to a subject |
| 05/28/2013 | US8449912 Sustained release compositions of alfuzosin |
| 05/28/2013 | US8449911 Drug composition having active ingredient adhered at high concentration to spherical core |
| 05/28/2013 | US8449910 Stable compositions of famotidine and ibuprofen |
| 05/28/2013 | US8449909 Abuse-deterrent drug formulations |
| 05/28/2013 | US8449908 Transdermal delivery of cannabidiol |
| 05/28/2013 | US8449907 Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
| 05/28/2013 | US8449906 Effervescent compositions comprising phosphonates and methods related thereto |
| 05/28/2013 | US8449902 Methods for producing biomaterials with variable stiffness |
| 05/28/2013 | US8449896 Pharmaceutical composition having improved solubility |
| 05/28/2013 | US8449890 Neprilysin inhibitors |
| 05/28/2013 | US8449878 Prebiotic formulations for use with probiotics to increase probiotic growth rate and activity |
| 05/28/2013 | US8449867 Microemulsion and sub-micron emulsion process and compositions |
| 05/28/2013 | US8449863 Stabilized uncoated particles of reversed liquid crystalline phase materials |
| 05/28/2013 | US8449324 Coaxial connector having detachable locking sleeve |
| 05/28/2013 | CA2731995C Method for inducing a cell-mediated immune response and parenteral vaccine formulations therefor |
| 05/28/2013 | CA2716994C Pharmaceutical compositions having desirable bioavailability |
| 05/28/2013 | CA2685447C Pharmaceutical composition |
| 05/28/2013 | CA2663558C Submicron nanoparticle of poorly water soluble camptothecin derivatives and process for preparation thereof |
| 05/28/2013 | CA2650698C Copolyvidone-containing preparation |
| 05/28/2013 | CA2599733C Methods and compositons for modified release of nutritional supplements |
| 05/28/2013 | CA2595033C Gastroresistant pharmaceutical formulations containing rifaximin |
| 05/28/2013 | CA2588338C Compositions comprising azelastine and methods of use thereof |
| 05/28/2013 | CA2587677C High concentration self-microemulsifying coenzyme q10 preparations for nutritional use |
| 05/28/2013 | CA2556212C Implantable drug delivery device including wire filaments |
| 05/28/2013 | CA2551183C Process for producing pellets for pharmaceutical compositions |
| 05/28/2013 | CA2533833C Oral delivery system comprising a biliquid foam |
| 05/28/2013 | CA2532475C Formulation for a protein pharmaceutical without added human serum albumin (hsa) |
| 05/28/2013 | CA2530385C Melt extruded controlled release oxycodone multiparticulates |
| 05/28/2013 | CA2500663C Enteric composition for the manufacture of soft capsule wall |
| 05/28/2013 | CA2477734C Suramin and derivatives thereof as topical microbicide and contraceptive |
| 05/28/2013 | CA2476935C Drug delivery system for subconjunctival administration of fine particles |
| 05/28/2013 | CA2473970C Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
| 05/28/2013 | CA2381468C Percutaneous absorption preparations containing melatonin receptor agonist for percutaneous treatment of sleep disorders |
| 05/28/2013 | CA2338022C Inhibitors of hiv membrane fusion |
| 05/28/2013 | CA2222455C A vaccine composition comprising a polysaccharide conjugate antigen adsorbed onto aluminium phosphate |
| 05/23/2013 | WO2013075068A1 Polymer protein microparticles |
| 05/23/2013 | WO2013074860A1 Polymeric colorant compositions and methods of use |
| 05/23/2013 | WO2013074648A1 Methods of preparing progesterone pharmaceutical compositions |
| 05/23/2013 | WO2013074628A1 Controlled release of active using ph |
| 05/23/2013 | WO2013074625A1 Suspensions of cyclosporin a form 2 |
| 05/23/2013 | WO2013074616A1 Autoclavable suspensions of cyclosporin a form 2 |
| 05/23/2013 | WO2013074610A1 Sustained action formulation of cyclosporin form 2 |
| 05/23/2013 | WO2013074432A1 Immediate release 4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-n-[5-(4-methyl- 1h-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide formulation |
| 05/23/2013 | WO2013074205A1 Liquid-filled hard gel capsule pharmaceutical formulations |
| 05/23/2013 | WO2013074055A1 Method for restoring and rejuvenating the human body and a pharmaceutical composition for implementation thereof |
| 05/23/2013 | WO2013074049A1 Micronized metformin |
| 05/23/2013 | WO2013074048A2 Tablet forms comprising quetiapine fumarate |
| 05/23/2013 | WO2013074046A1 Pharmaceutical formulations comprising isoflavone |
| 05/23/2013 | WO2013073926A1 Topical patch preparation for treatment of toxicity of mosquitoes |
| 05/23/2013 | WO2013073884A1 Oral complex formulation comprising omega-3 fatty acid and hmg-coa reductase inhibitor with improved stability |
| 05/23/2013 | WO2013073808A1 Vibrating stimulus pad |
| 05/23/2013 | WO2013073667A1 Intestinal fibrosis treatment agent |